Patents by Inventor Brian Wolff

Brian Wolff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9790081
    Abstract: Modularized components assembled dispensing nozzle, including operating components in the category of a poppet valve assembly, an automatic shutoff device, a hand operating lever for providing a turn on or shutoff of the dispensing of fluid through the nozzle, and a connected spout that delivers fluid to the fill pipe and fuel tank for a vehicle or fluid accepting container. Each of the identified components having been redesigned for assembly in modularized form, such as a modular cartridge for the poppet valve, a modular cartridge for the automatic shutoff device, a modularized operating hand lever, and a spout and its gland and retaining nut that provide for high speed interconnection with the nozzle body, during assembly, or servicing. Each of these modularized components can be installed, during assembly of the manufactured nozzle, or can be replaced, out in the field, by a service person, as a modularized component or cartridge assembly.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: October 17, 2017
    Assignee: Husky Corporation
    Inventors: Richard Benscoter, John Sever, Darrell Vilmer, Roger Wiersma, Brian Wolff
  • Publication number: 20150007907
    Abstract: Modularized components assembled dispensing nozzle, including operating components in the category of a poppet valve assembly, an automatic shutoff device, a hand operating lever for providing a turn on or shutoff of the dispensing of fluid through the nozzle, and a connected spout that delivers fluid to the fill pipe and fuel tank for a vehicle or fluid accepting container. Each of the identified components having been redesigned for assembly in modularized form, such as a modular cartridge for the poppet valve, a modular cartridge for the automatic shutoff device, a modularized operating hand lever, and a spout and its gland and retaining nut that provide for high speed interconnection with the nozzle body, during assembly, or servicing. Each of these modularized components can be installed, during assembly of the manufactured nozzle, or can be replaced, out in the field, by a service person, as a modularized component or cartridge assembly.
    Type: Application
    Filed: August 8, 2014
    Publication date: January 8, 2015
    Inventors: Richard Benscoter, John Sever, Darrell Vilmer, Roger Wiersma, Brian Wolff
  • Publication number: 20110232803
    Abstract: Modularized components assembled dispensing nozzle, including operating components in the category of a poppet valve assembly, an automatic shutoff device, a hand operating lever for providing a turn on or shutoff of the dispensing of fluid through the nozzle, and a connected spout that delivers fluid to the fill pipe and fuel tank for a vehicle or fluid accepting container. Each of the identified components having been redesigned for assembly in modularized form, such as a modular cartridge for the poppet valve, a modular cartridge for the automatic shutoff device, a modularized operating hand lever, and a spout and its gland and retaining nut that provide for high speed interconnection with the nozzle body, during assembly, or servicing. Each of these modularized components can be installed, during assembly of the manufactured nozzle, or can be replaced, out in the field, by a service person, as a modularized component or cartridge assembly.
    Type: Application
    Filed: March 9, 2011
    Publication date: September 29, 2011
    Inventors: Richard Benscoter, John Sever, Darrell Vilmer, Roger Wiersma, Brian Wolff
  • Patent number: 7112427
    Abstract: The present invention relates generally to novel protein molecules and to derivatives, analogues, chemical equivalents and mimetics thereof capable of modulating cellular activity and, in particular, modulating cellular activity via the modulation of signal transduction. More particularly, the present invention relates to human sphingosine kinase and to derivatives, analogues, chemical equivalents and mimetics thereof. The present invention also contemplates genetic sequences encoding said protein molecules and derivatives, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: September 26, 2006
    Assignee: Johnson & Johnson Pharmaceutical Research and Development LLC
    Inventors: Stuart Maxwell Pitson, Brian Wolff Wattenberg, Pu Xia, Richard James D'Andrea, Jennifer Ruth Gamble, Matthew Alexander Vadas
  • Publication number: 20040132053
    Abstract: The present invention relates generally to novel protein molecules and to derivatives, analogues, chemical equivalents and mimetics thereof capable of modulating cellular activity and, in particular, modulating cellular activity via the modulation of signal transduction. More particularly, the present invention relates to human sphingosine kinase and to derivatives, analogues, chemical equivalents and mimetics thereof. The present invention also contemplates genetic sequences encoding said protein molecules and derivatives, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic applications.
    Type: Application
    Filed: August 18, 2003
    Publication date: July 8, 2004
    Applicant: Johnson & Johnson Pharmaceutical R and D LLC
    Inventors: Stuart Maxwell Pitson, Brian Wolff Wattenberg, Pu Xia, Richard James D'Andrea, Jennifer Ruth Gamble, Matthew Alexander Vadas
  • Patent number: 6730480
    Abstract: The present invention relates generally to novel protein molecules and to derivatives, analogues, chemical equivalents and mimetics thereof capable of modulating cellular activity and, in particular, modulating cellular activity via the modulation of signal transduction. More particularly, the present invention relates to human sphingosine kinase and to derivatives, analogues, chemical equivalents and mimetics thereof. The present invention also contemplates genetic sequences encoding said protein molecules and derivatives, analogues, chemical equivalents and mimetics thereof. The molecules of the present invention are useful in a range of therapeutic, prophylactic and diagnostic application.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: May 4, 2004
    Assignee: Johnson & Johnson Pharmaceutical Research and Development LLC
    Inventors: Stuart Maxwell Pitson, Brian Wolff Wattenberg, Pu Xia, Richard James D'Andrea, Jennifer Ruth Gamble, Matthew Alexander Vadas